Drugs Made In America Acquisition Corp（DMAA）美股招股说明书 S-1 （2024-12-09修订版）（英文版）（185页）.pdf

《Drugs Made In America Acquisition Corp（DMAA）美股招股说明书 S-1 （2024-12-09修订版）（英文版）（185页）.pdf》由会员分享，可在线阅读，更多相关《Drugs Made In America Acquisition Corp（DMAA）美股招股说明书 S-1 （2024-12-09修订版）（英文版）（185页）.pdf（185页珍藏版）》请在三个皮匠报告上搜索。

1、S-1/A 1 ea0209546-08.htm REGISTRATION STATEMENTAs filed with the U.S.Securities and Exchange Commission underthe Securities Actof1933,as amended,on December 9,2024.Registration No.333-281170UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549_AMENDMENT NO.5TOFORM S-1REGISTRATION STATE

2、MENTUNDERTHE SECURITIES ACT OF 1933_Drugs Made In America Acquisition Corp.(Exact name of registrant as specified in its charter)_Cayman Islands677099-2394788(Stateorotherjurisdictionofincorporationororganization)(PrimaryStandardIndustrialClassificationCodeNumber)(I.R.S.EmployerIdentificationNumber)

3、Lynn StockwellChief Executive Officer and Executive ChairDrugs Made In America Acquisition Corp.1 East Broward Boulevard,Suite 700Fort Lauderdale,FL33301(954)870-3099(Address,including zip code,and telephone number,including area code,ofregistrants principal executive offices)_Copies to:Mitchell S.N

4、ussbaumG.Alex Weniger-AraujoLoeb&Loeb LLP345 Park AvenueNewYork,NY10154Tel:(212)407-4000Michael J.BlankenshipWinston&Strawn LLP800 Capitol Street,Suite 2400Houston,Texas 77002Tel:(713)651-2600_Approximate date of commencement of proposed sale to the public:As soon as practicableafter the effective d

5、ate of this registration statement.If any of the securities being registered on this Form are to be offered on a delayed or continuousbasis pursuant to Rule415 under the Securities Actof1933 check the following box:If this Form is filed to register additional securities for an offering pursuant toRu

6、le462(b)under the Securities Act,please check the following box and list the Securities Actregistration statement number of the earlier effective registration statement for the sameoffering.If this Form is a post-effective amendment filed pursuant to Rule462(c)under the Securities Act,check the foll